Last reviewed · How we verify
Diagnostic Test for Primary Aldosteronism
Approved treatments
- Spironolacton · ACS Biomarker
- Aldactone · Generic (originally Searle/Pfizer)
Potassium-sparing diuretic and mineralocorticoid receptor antagonist that blocks aldosterone, reducing fluid retention and lowering blood pressure. - spirolactone · Second Xiangya Hospital of Central South University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Diagnostic Test for Primary Aldosteronism patent landscape — cliff calendar, originator estates, attackable patents
- Diagnostic Test for Primary Aldosteronism treatment landscape brief
- Diagnostic Test for Primary Aldosteronism treatment updates RSS
Frequently asked questions about Diagnostic Test for Primary Aldosteronism
What drugs treat Diagnostic Test for Primary Aldosteronism?
Tracked treatments include Spironolacton, Aldactone, spirolactone.
What is the treatment for Diagnostic Test for Primary Aldosteronism?
Standard treatment for Diagnostic Test for Primary Aldosteronism includes Spironolacton, Aldactone, spirolactone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Diagnostic Test for Primary Aldosteronism patent cliff · Diagnostic Test for Primary Aldosteronism CI report
- Treatment: Spironolacton · ACS Biomarker
- Treatment: Aldactone · Generic (originally Searle/Pfizer)
- Treatment: spirolactone · Second Xiangya Hospital of Central South University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing